Bisphosphonates for osteoporosis prevention and treatment

By Jarvis Courtney   Morin Anna   Lynch Ann  

Clinical Review in Bone and Mineral Metabolism, Vol. 3, Iss. 1, 2005-03 ,pp. : 3-18

Humana Press, Inc

Access to resources Recommend Favorite

Bisphosphonates in the Treatment of Thalassemia-Induced Osteoporosis

By Morabito N.   Lasco A.   Gaudio A.   Crisafulli A.   Di Pietro C.   Meo A.   Frisina N.  

Osteoporosis International, Vol. 13, Iss. 8, 2002-08 ,pp. : 644-649

Springer Publishing Company

Access to resources Recommend Favorite

Long-term use of bisphosphonates in osteoporosis

By Rizzoli René  

Women's Health, Vol. 2, Iss. 2, 2006-03 ,pp. : 309-315

Future Medicine

Access to resources Recommend Favorite

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report

By Rizzoli R.   Åkesson K.   Bouxsein M.   Kanis J.   Napoli N.   Papapoulos S.   Reginster J.-Y.   Cooper C.  

Osteoporosis International, Vol. 22, Iss. 2, 2011-02 ,pp. : 373-390

Springer Publishing Company

Access to resources Recommend Favorite

Less frequent dosing of bisphosphonates in osteoporosis: focus on ibandronate

By Simonelli Christine   Burke M. Susan  

Current Medical Research and Opinion, Vol. 22, Iss. 6, 2006-06 ,pp. : 1101-1108

Informa Healthcare

Access to resources Recommend Favorite